Correlation Between Mobiquity Technologies and TC BioPharm

Can any of the company-specific risk be diversified away by investing in both Mobiquity Technologies and TC BioPharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mobiquity Technologies and TC BioPharm into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mobiquity Technologies and TC BioPharm Holdings, you can compare the effects of market volatilities on Mobiquity Technologies and TC BioPharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mobiquity Technologies with a short position of TC BioPharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mobiquity Technologies and TC BioPharm.

Diversification Opportunities for Mobiquity Technologies and TC BioPharm

0.0

Correlation Coefficient

Mobiquity Technologies  TC BioPharm

Pay attention - limited upside

The 3 months correlation between Mobiquity and TCBP is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Mobiquity Technologies and TC BioPharm Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TC BioPharm Holdings and Mobiquity Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mobiquity Technologies are associated (or correlated) with TC BioPharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TC BioPharm Holdings has no effect on the direction of Mobiquity Technologies i.e., Mobiquity Technologies and TC BioPharm go up and down completely randomly.

Pair Corralation between Mobiquity Technologies and TC BioPharm

If you would invest (100.00) in Mobiquity Technologies on December 29, 2024 and sell it today you would earn a total of  100.00  from holding Mobiquity Technologies or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Mobiquity Technologies  vs.  TC BioPharm Holdings

Mobiquity Technologies

Risk-Adjusted Performance

Very Weak

Over the last 90 days Mobiquity Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Mobiquity Technologies is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.

TC BioPharm Holdings

Risk-Adjusted Performance

Very Weak

Over the last 90 days TC BioPharm Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's fundamental drivers remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Mobiquity Technologies and TC BioPharm

The main advantage of trading using opposite Mobiquity Technologies and TC BioPharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mobiquity Technologies position performs unexpectedly, TC BioPharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TC BioPharm will offset losses from the drop in TC BioPharm's long position.

The idea behind Mobiquity Technologies and TC BioPharm Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.